Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History
Product details
| Management number | 233421136 | Release Date | 2026/06/27 | List Price | US$14.24 | Model Number | 233421136 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
The remarkable story behind the revolutionary miracle cure for cancer, Gleevec. Novartis chairman Dr Dan Vasella describes its development and how he and Novartis orchestrated the break–neck approval and massive production of this amazing drug. Pharmaceutical giant Novartis recently developed Gleevec, one of the first 'smart' drugs created to kill cancer cells without damaging healthy cells in the process. In early tests with a common form of leukemia and other types of cancer, Gleevec has been extraordinarily successful, and side effects have been astoundingly minimal. Gleevec communicates directly with cancer–causing chromosomes and interrupts the signal that causes excessive growth of certain white blood cells. Patients have seen their tumours shrink significantly, and some have disappeared altogether. This is the inside story of the creation of this miracle drug, and how Novartis CEO and chairman Dan Vasella rallied the company to bring Gleevec to market in mass quantities and record time. Read more
| ISBN10 | 0060010304 |
|---|---|
| ISBN13 | 978-0060010300 |
| Edition | 1st |
| Language | English |
| Publisher | Harper Business |
| Dimensions | 6 x 0.93 x 9 inches |
| Item Weight | 1.1 pounds |
| Print length | 288 pages |
| Publication date | June 1, 2003 |
Bestseller ranking
Water Pumps
Customers who viewed this product also viewed
Research
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form